ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.785
+0.135 (8.16%)
Nov 21, 2024, 1:04 PM EST - Market open
ProKidney Employees
ProKidney had 163 employees as of December 31, 2023. The number of employees increased by 76 or 87.36% compared to the previous year.
Employees
163
Change (1Y)
76
Growth (1Y)
87.36%
Revenue / Employee
n/a
Profits / Employee
-$279,810
Market Cap
520.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 163 | 76 | 87.36% |
| Dec 31, 2022 | 87 | 28 | 47.46% |
| Dec 31, 2021 | 59 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fulgent Genetics | 1,184 |
| Talkspace | 472 |
| SI-BONE | 344 |
| Sana Biotechnology | 328 |
| Monte Rosa Therapeutics | 133 |
| Altimmune | 59 |
| Mind Medicine (MindMed) | 57 |
| Opthea | 33 |
PROK News
- 9 days ago - ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting - GlobeNewsWire
- 16 days ago - ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference - GlobeNewsWire
- 5 weeks ago - ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024 - GlobeNewsWire
- 6 weeks ago - ProKidney to Participate in the UBS Virtual Organ Restoration Day - GlobeNewsWire
- 2 months ago - ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S. - GlobeNewsWire
- 3 months ago - ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - ProKidney Reports Business Updates and Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering - GlobeNewsWire